AstaPure Astaxanthin’s Recommended Shelf Life Extended
AstaPure astaxanthin now has the green light for an even longer shelf life-four years at room temperature.
AstaPure astaxanthin now has the green light for an even longer shelf life-four years at room temperature-due to stability data announced by supplier Algatechnologies (Kibbutz Ketura, Israel). The company says this shelf life surpasses those of other astaxanthin brands.
The recommendation comes from more than four years of the company’s own real-time stability studies. It tested how various environmental conditions, including air, heat, and light, affect the concentration of astaxanthin in finished products.
“In light of the impressive results of the study, we are able to extend AstaPure’s shelf life at room temperature with complete confidence, providing that the packages remain sealed in their original containers,” said Oran Ayalon, PhD, the company’s R&D director, in a press release. He said refrigeration helps improve shelf-life conditions even further.
AstaPure is a microalgae-derived, 10% astaxanthin oleoresin.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
